Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype Cover

Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype

Radiology and Oncology

Volume 50 (2016): Issue 4 (December 2016)

By:

Marijana Virijevic, Teodora Karan-Djurasevic, Irena Marjanovic, Natasa Tosic, Mirjana Mitrovic, Irena Djunic, Natasa Colovic, Ana Vidovic, Nada Suvajdzic-Vukovic, Dragica Tomin and Sonja Pavlovic

Open Access

|Sep 2016

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.1515/raon-2016-0044 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 385 - 393

Submitted on: Mar 28, 2016

Accepted on: Jun 18, 2016

Published on: Sep 8, 2016

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

acute myeloid leukaemia,

normal karyotype

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2016 Marijana Virijevic, Teodora Karan-Djurasevic, Irena Marjanovic, Natasa Tosic, Mirjana Mitrovic, Irena Djunic, Natasa Colovic, Ana Vidovic, Nada Suvajdzic-Vukovic, Dragica Tomin, Sonja Pavlovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 50 (2016): Issue 4 (December 2016)Next article